Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow Reinvestment Rate
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥123.12 Million (capex CN¥123.12 Million ) from operating cash flow of CN¥345.31 Million. See how much free cash does Jiangsu Hualv Biological Technology Co.L generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. For the full cash flow conversion analysis, see Jiangsu Hualv Biological Technology Co.L operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year capital reinvestment analysis for Jiangsu Hualv Biological Technology Co.Ltd.. See 300970 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | CN¥123.12 Million | CN¥345.31 Million | CN¥123.12 Million | ▼ -90.8% |
| 2024 | 3.89x | CN¥536.45 Million | CN¥137.80 Million | CN¥268.22 Million | ▲ +100.0% |
| 2023 | 1.95x | CN¥324.39 Million | CN¥166.67 Million | CN¥224.15 Million | ▼ -15.3% |
| 2022 | 2.30x | CN¥413.20 Million | CN¥179.84 Million | CN¥407.91 Million | ▼ -77.5% |
| 2021 | 10.20x | CN¥847.81 Million | CN¥83.08 Million | CN¥204.09 Million | ▲ +487.3% |
| 2020 | 1.74x | CN¥345.91 Million | CN¥199.09 Million | CN¥190.96 Million | ▲ +39.1% |
| 2019 | 1.25x | CN¥267.34 Million | CN¥213.96 Million | CN¥98.54 Million | — |